- Home
- CNO vs RNA Comparison
CNO vs RNA Comparison
Compare CNO & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNO
- RNA
- Stock Information
- Founded
- CNO 1979
- RNA 2012
- Country
- CNO United States
- RNA United States
- Employees
- CNO N/A
- RNA N/A
- Industry
- CNO Accident &Health Insurance
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- CNO Finance
- RNA Health Care
- Exchange
- CNO Nasdaq
- RNA Nasdaq
- Market Cap
- CNO 4.1B
- RNA 3.7B
- IPO Year
- CNO 1987
- RNA 2020
- Fundamental
- Price
- CNO $39.79
- RNA $31.12
- Analyst Decision
- CNO Hold
- RNA Strong Buy
- Analyst Count
- CNO 6
- RNA 10
- Target Price
- CNO $40.50
- RNA $65.80
- AVG Volume (30 Days)
- CNO 575.1K
- RNA 1.3M
- Earning Date
- CNO 02-06-2025
- RNA 03-07-2025
- Dividend Yield
- CNO 1.60%
- RNA N/A
- EPS Growth
- CNO 55.83
- RNA N/A
- EPS
- CNO 3.74
- RNA N/A
- Revenue
- CNO $4,449,500,000.00
- RNA $10,117,000.00
- Revenue This Year
- CNO N/A
- RNA N/A
- Revenue Next Year
- CNO $2.73
- RNA N/A
- P/E Ratio
- CNO $10.67
- RNA N/A
- Revenue Growth
- CNO 7.30
- RNA N/A
- 52 Week Low
- CNO $24.92
- RNA $13.73
- 52 Week High
- CNO $42.02
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- CNO 48.33
- RNA 44.06
- Support Level
- CNO $40.44
- RNA $31.14
- Resistance Level
- CNO $42.02
- RNA $33.37
- Average True Range (ATR)
- CNO 0.84
- RNA 1.67
- MACD
- CNO -0.10
- RNA -0.16
- Stochastic Oscillator
- CNO 26.40
- RNA 11.27
About CNO CNO Financial Group Inc.
CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.